PATHEON UK LIMITED

Figures converted to GBP from EUR at 0.870 per EUR (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -3.9%

  £858,103,313 → £825,020,437

• Cash

  —

  Not reported

• Net assets

  +20.4%

  £701,726,237 → £845,082,181

• Employees

  -19.7%

  553 → 444

• Operating profit

  -30.4%

  £189,875,641 → £132,181,929

• Profit before tax

  -25%

  £186,999,739 → £140,306,983

• Wages

  +1.7%

  £32,068,006 → £32,601,096

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. PATHEON UK LIMITED 1999-07-02 → present
2. PATHEON LIMITED 1999-04-29 → 1999-07-02

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company has adequate resource to continue its operation for at least 12 months from the date of approving these financial statements. The directors have also received confirmation that Thermo Fisher Scientific Inc. will financially support the company for at least one year after these financial statements are approved and it will provide adequate funds when necessary to enable it to meet its debts as they fall due in the foreseeable future.”

Group structure

1. PATHEON UK LIMITED · parent
   1. Patheon UK Pension Trustees Limited 100% · UK · Dormant
   2. Thermo Fisher Scientific (PN) UK LLC 100% · US · Trading
   3. Thermo Fisher Scientific (PN) UK Limited Partnership 99% · US · Holding Company
   4. Patheon Calculus Merger LLC 100% · US · Holding Company

Significant events

• “In March 2023, the company received information from a significant client that there would not be any future purchase commitments for the site. On 30 June 2023, the company signed an official termination agreement with the client.”
• “The site additionally initiated a reduction-in-force program. The contracts of a group of employees were terminated in accordance with the final terms of the severance packages. The company recognised €2,191,000 of severance costs in 2023.”
• “In October 2023, it was announced that the Milton Park facility would close, with customer contracts being transferred to the Patheon France SAS facility and Patheon UK Limited still acting as principal. The number of staff affected by the closure is 44 with severance costs of €1,789,000 recognised in 2023 with all staff exiting and the facility closed by June 2024.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.